Sebastian Schneeweiss
Overview
Explore the profile of Sebastian Schneeweiss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
521
Citations
16884
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang S, Russo M, Glynn R, Bradley M, He J, Concato J, et al.
Clin Pharmacol Ther
. 2025 Mar;
PMID: 40067205
Real-world evidence involving healthcare database studies is well established for making causal inferences in post-market drug safety studies and methods, data, and research infrastructure for evaluating effectiveness have advanced in...
2.
Okonkwo J, Williams E, Sadjadi R, Schneeweiss S, Anderson-Smits C, Ay H, et al.
Pharmacoepidemiol Drug Saf
. 2025 Mar;
34(3):e70123.
PMID: 40025632
Purpose: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare autoimmune condition of the peripheral nervous system. The validity of the CIDP diagnosis code in claims data is unclear. Methods: We...
3.
Wyss R, Yang J, Schneeweiss S, Plasek J, Zhou L, Deramus T, et al.
medRxiv
. 2025 Feb;
PMID: 39974094
Background: To improve confounding control in healthcare database studies, data-driven algorithms may empirically identify and adjust for large numbers of pre-exposure variables that indirectly capture information on unmeasured confounding factors...
4.
Weberpals J, Shaw P, Lin K, Wyss R, Plasek J, Zhou L, et al.
Am J Epidemiol
. 2025 Jan;
PMID: 39844590
Multiple imputation (MI) models can be improved with auxiliary covariates (AC), but their performance in high-dimensional data remains unclear. We aimed to develop and compare high-dimensional MI (HDMI) methods using...
5.
Feldman W, Suissa S, Kesselheim A, Avorn J, Russo M, Schneeweiss S, et al.
BMJ
. 2025 Jan;
387():e080409.
PMID: 39797646
Objective: To compare the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once daily dry powder inhaler, in patients with chronic obstructive pulmonary disease...
6.
Lindsay A, Walker A, Schneeweiss S
J Am Heart Assoc
. 2024 Dec;
14(1):e035689.
PMID: 39719418
Background: Immune checkpoint inhibitors have improved the clinical outcomes of several cancers but have also been associated with a greater risk of immune-related adverse effects, especially when combined. The objective...
7.
Desai R, Marsolo K, Smith J, Carrell D, Penfold R, Pillai H, et al.
Pharmacoepidemiol Drug Saf
. 2024 Oct;
33(10):e70028.
PMID: 39385712
Purpose: The US Food and Drug Administration's Sentinel Innovation Center aimed to establish a query-ready, quality-checked distributed data network containing electronic health records (EHRs) linked with insurance claims data for...
8.
Schneeweiss M, Glynn R, Wyss R, Anand P, Jin Y, Landon J, et al.
J Invest Dermatol
. 2024 Oct;
PMID: 39362623
Targeted systemic immune-modulating drugs to treat atopic dermatitis were highly efficacious in randomized trials. Trials with limited number of subjects leave questions about their safety. We describe a data and...
9.
Merola D, Campbell U, Lenis D, Schneeweiss S, Wang S, Madsen A, et al.
JAMA Netw Open
. 2024 Sep;
7(9):e2436535.
PMID: 39348118
Importance: The conditions required for health record data sources to accurately assess treatment effectiveness remain unclear. Emulation of randomized clinical trials (RCTs) with health record data and subsequent calibration of...
10.
Tazare J, Wang S, Gini R, Prieto-Alhambra D, Arlett P, Morales Leaver D, et al.
Pharmacoepidemiol Drug Saf
. 2024 Sep;
33(9):e5856.
PMID: 39233394
Purpose: There is increasing recognition of the importance of transparency and reproducibility in scientific research. This study aimed to quantify the extent to which programming code is publicly shared in...